Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
25.4M
-
Shares change
-
-1.19M
-
Total reported value, excl. options
-
$101M
-
Value change
-
-$4.41M
-
Number of buys
-
32
-
Number of sells
-
-24
-
Price
-
$3.96
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2017
72 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q3 2017.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.4M shares
of 114M outstanding shares and own 22.22% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (6.08M shares), FMR LLC (3.97M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), EcoR1 Capital, LLC (2.26M shares), BlackRock Inc. (1.66M shares), Redmile Group, LLC (1.42M shares), VANGUARD GROUP INC (1.28M shares), 683 Capital Management, LLC (679K shares), MORGAN STANLEY (581K shares), and Casdin Capital, LLC (550K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.